世界の爪真菌症市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Onychomycosis Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4267 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、爪真菌症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（遠位爪下爪真菌症、白色表在性爪真菌症、近位爪下爪真菌症、カンジダ爪真菌症、その他）、用途別市場規模（病院薬局、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・爪真菌症の市場動向 ・企業の競争状況、市場シェア ・爪真菌症の種類別市場規模（遠位爪下爪真菌症、白色表在性爪真菌症、近位爪下爪真菌症、カンジダ爪真菌症、その他） ・爪真菌症の用途別市場規模（病院薬局、ドラッグストア、その他） ・爪真菌症の北米市場規模2016-2027（アメリカ、カナダ） ・爪真菌症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・爪真菌症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・爪真菌症の中南米市場規模2016-2027（メキシコ、ブラジル） ・爪真菌症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Glaxosmithkline、Pfizer、Bausch Health、Galderma、Janssen Biotech、Bristol Meyer Squibb、Topica Pharmaceuticals、Sanofi、Novartis） ・結論

Onychomycosis, also known as tinea unguium, is a fungal infection of the nail. Symptoms may include white or yellow nail discoloration, thickening of the nail, and separation of the nail from the nail bed. Toenails or fingernails may be affected, but it is more common for toenails to be affected. Complications may include cellulitis of the lower leg.
Onychomycosis occurs in about 10 percent of the adult population. Older people are more frequently affected. Males are affected more often than females. Onychomycosis represents about half of nail disease.

Market Analysis and Insights: Global Onychomycosis Market
The global Onychomycosis market size is projected to reach US$ 14020 million by 2026, from US$ 9075.2 million in 2019, at a CAGR of 6.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Onychomycosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Onychomycosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Onychomycosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Onychomycosis market.

Global Onychomycosis Scope and Market Size
Onychomycosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Onychomycosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Distal Subungual Onychomycosis
White Superficial Onychomycosis
Proximal Subungual Onychomycosis
Candida Onychomycosis
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Glaxosmithkline
Pfizer
Bausch Health
Galderma
Janssen Biotech
Bristol Meyer Squibb
Topica Pharmaceuticals
Sanofi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Onychomycosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Distal Subungual Onychomycosis
1.2.3 White Superficial Onychomycosis
1.2.4 Proximal Subungual Onychomycosis
1.2.5 Candida Onychomycosis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Onychomycosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Onychomycosis Market Perspective (2016-2027)
2.2 Onychomycosis Growth Trends by Regions
2.2.1 Onychomycosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Onychomycosis Historic Market Share by Regions (2016-2021)
2.2.3 Onychomycosis Forecasted Market Size by Regions (2022-2027)
2.3 Onychomycosis Industry Dynamic
2.3.1 Onychomycosis Market Trends
2.3.2 Onychomycosis Market Drivers
2.3.3 Onychomycosis Market Challenges
2.3.4 Onychomycosis Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Onychomycosis Players by Revenue
3.1.1 Global Top Onychomycosis Players by Revenue (2016-2021)
3.1.2 Global Onychomycosis Revenue Market Share by Players (2016-2021)
3.2 Global Onychomycosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Onychomycosis Revenue
3.4 Global Onychomycosis Market Concentration Ratio
3.4.1 Global Onychomycosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Onychomycosis Revenue in 2020
3.5 Onychomycosis Key Players Head office and Area Served
3.6 Key Players Onychomycosis Product Solution and Service
3.7 Date of Enter into Onychomycosis Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Onychomycosis Breakdown Data by Type
4.1 Global Onychomycosis Historic Market Size by Type (2016-2021)
4.2 Global Onychomycosis Forecasted Market Size by Type (2022-2027)

5 Onychomycosis Breakdown Data by Application
5.1 Global Onychomycosis Historic Market Size by Application (2016-2021)
5.2 Global Onychomycosis Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Onychomycosis Market Size (2016-2027)
6.2 North America Onychomycosis Market Size by Type
6.2.1 North America Onychomycosis Market Size by Type (2016-2021)
6.2.2 North America Onychomycosis Market Size by Type (2022-2027)
6.2.3 North America Onychomycosis Market Size by Type (2016-2027)
6.3 North America Onychomycosis Market Size by Application
6.3.1 North America Onychomycosis Market Size by Application (2016-2021)
6.3.2 North America Onychomycosis Market Size by Application (2022-2027)
6.3.3 North America Onychomycosis Market Size by Application (2016-2027)
6.4 North America Onychomycosis Market Size by Country
6.4.1 North America Onychomycosis Market Size by Country (2016-2021)
6.4.2 North America Onychomycosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Onychomycosis Market Size (2016-2027)
7.2 Europe Onychomycosis Market Size by Type
7.2.1 Europe Onychomycosis Market Size by Type (2016-2021)
7.2.2 Europe Onychomycosis Market Size by Type (2022-2027)
7.2.3 Europe Onychomycosis Market Size by Type (2016-2027)
7.3 Europe Onychomycosis Market Size by Application
7.3.1 Europe Onychomycosis Market Size by Application (2016-2021)
7.3.2 Europe Onychomycosis Market Size by Application (2022-2027)
7.3.3 Europe Onychomycosis Market Size by Application (2016-2027)
7.4 Europe Onychomycosis Market Size by Country
7.4.1 Europe Onychomycosis Market Size by Country (2016-2021)
7.4.2 Europe Onychomycosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Onychomycosis Market Size (2016-2027)
8.2 Asia-Pacific Onychomycosis Market Size by Type
8.2.1 Asia-Pacific Onychomycosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Onychomycosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Onychomycosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Onychomycosis Market Size by Application
8.3.1 Asia-Pacific Onychomycosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Onychomycosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Onychomycosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Onychomycosis Market Size by Region
8.4.1 Asia-Pacific Onychomycosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Onychomycosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Onychomycosis Market Size (2016-2027)
9.2 Latin America Onychomycosis Market Size by Type
9.2.1 Latin America Onychomycosis Market Size by Type (2016-2021)
9.2.2 Latin America Onychomycosis Market Size by Type (2022-2027)
9.2.3 Latin America Onychomycosis Market Size by Type (2016-2027)
9.3 Latin America Onychomycosis Market Size by Application
9.3.1 Latin America Onychomycosis Market Size by Application (2016-2021)
9.3.2 Latin America Onychomycosis Market Size by Application (2022-2027)
9.3.3 Latin America Onychomycosis Market Size by Application (2016-2027)
9.4 Latin America Onychomycosis Market Size by Country
9.4.1 Latin America Onychomycosis Market Size by Country (2016-2021)
9.4.2 Latin America Onychomycosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Onychomycosis Market Size (2016-2027)
10.2 Middle East & Africa Onychomycosis Market Size by Type
10.2.1 Middle East & Africa Onychomycosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Onychomycosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Onychomycosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Onychomycosis Market Size by Application
10.3.1 Middle East & Africa Onychomycosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Onychomycosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Onychomycosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Onychomycosis Market Size by Country
10.4.1 Middle East & Africa Onychomycosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Onychomycosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Onychomycosis Introduction
11.1.4 Abbott Laboratories Revenue in Onychomycosis Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Glaxosmithkline
11.2.1 Glaxosmithkline Company Details
11.2.2 Glaxosmithkline Business Overview
11.2.3 Glaxosmithkline Onychomycosis Introduction
11.2.4 Glaxosmithkline Revenue in Onychomycosis Business (2016-2021)
11.2.5 Glaxosmithkline Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Onychomycosis Introduction
11.3.4 Pfizer Revenue in Onychomycosis Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Bausch Health
11.4.1 Bausch Health Company Details
11.4.2 Bausch Health Business Overview
11.4.3 Bausch Health Onychomycosis Introduction
11.4.4 Bausch Health Revenue in Onychomycosis Business (2016-2021)
11.4.5 Bausch Health Recent Development
11.5 Galderma
11.5.1 Galderma Company Details
11.5.2 Galderma Business Overview
11.5.3 Galderma Onychomycosis Introduction
11.5.4 Galderma Revenue in Onychomycosis Business (2016-2021)
11.5.5 Galderma Recent Development
11.6 Janssen Biotech
11.6.1 Janssen Biotech Company Details
11.6.2 Janssen Biotech Business Overview
11.6.3 Janssen Biotech Onychomycosis Introduction
11.6.4 Janssen Biotech Revenue in Onychomycosis Business (2016-2021)
11.6.5 Janssen Biotech Recent Development
11.7 Bristol Meyer Squibb
11.7.1 Bristol Meyer Squibb Company Details
11.7.2 Bristol Meyer Squibb Business Overview
11.7.3 Bristol Meyer Squibb Onychomycosis Introduction
11.7.4 Bristol Meyer Squibb Revenue in Onychomycosis Business (2016-2021)
11.7.5 Bristol Meyer Squibb Recent Development
11.8 Topica Pharmaceuticals
11.8.1 Topica Pharmaceuticals Company Details
11.8.2 Topica Pharmaceuticals Business Overview
11.8.3 Topica Pharmaceuticals Onychomycosis Introduction
11.8.4 Topica Pharmaceuticals Revenue in Onychomycosis Business (2016-2021)
11.8.5 Topica Pharmaceuticals Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Onychomycosis Introduction
11.9.4 Sanofi Revenue in Onychomycosis Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Onychomycosis Introduction
11.10.4 Novartis Revenue in Onychomycosis Business (2016-2021)
11.10.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Onychomycosis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Distal Subungual Onychomycosis
Table 3. Key Players of White Superficial Onychomycosis
Table 4. Key Players of Proximal Subungual Onychomycosis
Table 5. Key Players of Candida Onychomycosis
Table 6. Key Players of Others
Table 7. Global Onychomycosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Onychomycosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Onychomycosis Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Onychomycosis Market Share by Regions (2016-2021)
Table 11. Global Onychomycosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Onychomycosis Market Share by Regions (2022-2027)
Table 13. Onychomycosis Market Trends
Table 14. Onychomycosis Market Drivers
Table 15. Onychomycosis Market Challenges
Table 16. Onychomycosis Market Restraints
Table 17. Global Onychomycosis Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Onychomycosis Market Share by Players (2016-2021)
Table 19. Global Top Onychomycosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Onychomycosis as of 2020)
Table 20. Ranking of Global Top Onychomycosis Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Onychomycosis Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Onychomycosis Product Solution and Service
Table 24. Date of Enter into Onychomycosis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Onychomycosis Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Onychomycosis Revenue Market Share by Type (2016-2021)
Table 28. Global Onychomycosis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Onychomycosis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Onychomycosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Onychomycosis Revenue Market Share by Application (2016-2021)
Table 32. Global Onychomycosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Onychomycosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Onychomycosis Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Onychomycosis Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Onychomycosis Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Onychomycosis Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Onychomycosis Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Onychomycosis Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Onychomycosis Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Onychomycosis Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Onychomycosis Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Onychomycosis Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Onychomycosis Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Onychomycosis Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Onychomycosis Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Onychomycosis Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Onychomycosis Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Onychomycosis Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Onychomycosis Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Onychomycosis Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Onychomycosis Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Onychomycosis Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Onychomycosis Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Onychomycosis Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Onychomycosis Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Onychomycosis Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Onychomycosis Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Onychomycosis Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Onychomycosis Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Onychomycosis Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Onychomycosis Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Onychomycosis Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Onychomycosis Product
Table 67. Abbott Laboratories Revenue in Onychomycosis Business (2016-2021) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Glaxosmithkline Company Details
Table 70. Glaxosmithkline Business Overview
Table 71. Glaxosmithkline Onychomycosis Product
Table 72. Glaxosmithkline Revenue in Onychomycosis Business (2016-2021) & (US$ Million)
Table 73. Glaxosmithkline Recent Development
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Onychomycosis Product
Table 77. Pfizer Revenue in Onychomycosis Business (2016-2021) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. Bausch Health Company Details
Table 80. Bausch Health Business Overview
Table 81. Bausch Health Onychomycosis Product
Table 82. Bausch Health Revenue in Onychomycosis Business (2016-2021) & (US$ Million)
Table 83. Bausch Health Recent Development
Table 84. Galderma Company Details
Table 85. Galderma Business Overview
Table 86. Galderma Onychomycosis Product
Table 87. Galderma Revenue in Onychomycosis Business (2016-2021) & (US$ Million)
Table 88. Galderma Recent Development
Table 89. Janssen Biotech Company Details
Table 90. Janssen Biotech Business Overview
Table 91. Janssen Biotech Onychomycosis Product
Table 92. Janssen Biotech Revenue in Onychomycosis Business (2016-2021) & (US$ Million)
Table 93. Janssen Biotech Recent Development
Table 94. Bristol Meyer Squibb Company Details
Table 95. Bristol Meyer Squibb Business Overview
Table 96. Bristol Meyer Squibb Onychomycosis Product
Table 97. Bristol Meyer Squibb Revenue in Onychomycosis Business (2016-2021) & (US$ Million)
Table 98. Bristol Meyer Squibb Recent Development
Table 99. Topica Pharmaceuticals Company Details
Table 100. Topica Pharmaceuticals Business Overview
Table 101. Topica Pharmaceuticals Revenue in Onychomycosis Business (2016-2021) & (US$ Million)
Table 102. Topica Pharmaceuticals Recent Development
Table 103. Sanofi Company Details
Table 104. Sanofi Business Overview
Table 105. Sanofi Onychomycosis Product
Table 106. Sanofi Revenue in Onychomycosis Business (2016-2021) & (US$ Million)
Table 107. Sanofi Recent Development
Table 108. Novartis Company Details
Table 109. Novartis Business Overview
Table 110. Novartis Onychomycosis Product
Table 111. Novartis Revenue in Onychomycosis Business (2016-2021) & (US$ Million)
Table 112. Novartis Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Onychomycosis Market Share by Type: 2020 VS 2027
Figure 2. Distal Subungual Onychomycosis Features
Figure 3. White Superficial Onychomycosis Features
Figure 4. Proximal Subungual Onychomycosis Features
Figure 5. Candida Onychomycosis Features
Figure 6. Others Features
Figure 7. Global Onychomycosis Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Onychomycosis Report Years Considered
Figure 12. Global Onychomycosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Onychomycosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Onychomycosis Market Share by Regions: 2020 VS 2027
Figure 15. Global Onychomycosis Market Share by Regions (2022-2027)
Figure 16. Global Onychomycosis Market Share by Players in 2020
Figure 17. Global Top Onychomycosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Onychomycosis as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Onychomycosis Revenue in 2020
Figure 19. Global Onychomycosis Revenue Market Share by Type (2016-2021)
Figure 20. Global Onychomycosis Revenue Market Share by Type (2022-2027)
Figure 21. North America Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Onychomycosis Market Share by Type (2016-2027)
Figure 23. North America Onychomycosis Market Share by Application (2016-2027)
Figure 24. North America Onychomycosis Market Share by Country (2016-2027)
Figure 25. United States Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Onychomycosis Market Share by Type (2016-2027)
Figure 29. Europe Onychomycosis Market Share by Application (2016-2027)
Figure 30. Europe Onychomycosis Market Share by Country (2016-2027)
Figure 31. Germany Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Onychomycosis Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Onychomycosis Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Onychomycosis Market Share by Region (2016-2027)
Figure 41. China Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Onychomycosis Market Share by Type (2016-2027)
Figure 49. Latin America Onychomycosis Market Share by Application (2016-2027)
Figure 50. Latin America Onychomycosis Market Share by Country (2016-2027)
Figure 51. Mexico Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Onychomycosis Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Onychomycosis Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Onychomycosis Market Share by Country (2016-2027)
Figure 57. Turkey Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Onychomycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Laboratories Revenue Growth Rate in Onychomycosis Business (2016-2021)
Figure 61. Glaxosmithkline Revenue Growth Rate in Onychomycosis Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Onychomycosis Business (2016-2021)
Figure 63. Bausch Health Revenue Growth Rate in Onychomycosis Business (2016-2021)
Figure 64. Galderma Revenue Growth Rate in Onychomycosis Business (2016-2021)
Figure 65. Janssen Biotech Revenue Growth Rate in Onychomycosis Business (2016-2021)
Figure 66. Bristol Meyer Squibb Revenue Growth Rate in Onychomycosis Business (2016-2021)
Figure 67. Topica Pharmaceuticals Revenue Growth Rate in Onychomycosis Business (2016-2021)
Figure 68. Sanofi Revenue Growth Rate in Onychomycosis Business (2016-2021)
Figure 69. Novartis Revenue Growth Rate in Onychomycosis Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---